Industrials [ 4/12 ] | Trading Companies & Distributors [ 23/73 ]
NYSE MKT | Common Stock
IGC Pharma, Inc., a clinical stage pharmaceutical company, engages in developing treatments for Alzheimer's disease in India, the United States, and Colombia.
The company's lead product is IGC-AD1, which is in Phase 2 clinical trial for the treatment of agitation in dementia due to Alzheimer's; and TGR-63, IGC-M3, and LMP that are in pre-clinical stage for the treatment of Alzheimer's disease.
It also develops IGC-1A and IGC-1C which are in pre-clinical stage for the treatment of metabolic disorders and Alzheimer's disease.
The company was formerly known as India Globalization Capital, Inc. and changed its name to IGC Pharma, Inc. in March 2023.
IGC Pharma, Inc. was incorporated in 2005 and is headquartered in Potomac, Maryland.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Jun 30, 25 | -0.02 Increased by +95.00% | -0.02 |
| Feb 12, 25 | -0.02 Increased by +77.78% | -0.03 Increased by +33.33% |
| Nov 7, 24 | -0.02 Increased by +60.00% | -0.03 Increased by +33.33% |
| Aug 7, 24 | -0.03 Increased by +25.00% | -0.03 |
| Jun 24, 24 | -0.40 Decreased by -427.01% | -0.04 Decreased by -900.00% |
| Feb 14, 24 | -0.09 Decreased by -112.26% | -0.04 Decreased by -125.00% |
| Nov 9, 23 | -0.05 Decreased by -6.84% | -0.05 |
| Aug 10, 23 | -0.04 Increased by +20.00% | - |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Mar 31, 25 | 330.00 K Increased by +11.86% | -1.20 M Increased by +58.51% | Decreased by -362.73% Increased by +62.91% |
| Dec 31, 24 | 257.00 K Increased by +25.98% | -1.83 M Increased by +67.28% | Decreased by -711.67% Increased by +74.02% |
| Sep 30, 24 | 412.00 K Increased by +41.58% | -1.72 M Increased by +29.95% | Decreased by -416.75% Increased by +50.52% |
| Jun 30, 24 | 272.00 K Decreased by -50.99% | -2.38 M Decreased by -14.60% | Decreased by -874.26% Decreased by -133.84% |
| Mar 31, 24 | 295.00 K Increased by +77.71% | -2.88 M Increased by +28.41% | Decreased by -977.97% Increased by +59.72% |
| Dec 31, 23 | 204.00 K Decreased by -38.55% | -5.59 M Decreased by -148.51% | Decreased by -2.74 K% Decreased by -304.44% |
| Sep 30, 23 | 291.00 K Increased by +44.06% | -2.45 M Decreased by -0.37% | Decreased by -842.27% Increased by +30.33% |
| Jun 30, 23 | 555.00 K Increased by +161.79% | -2.08 M Increased by +25.49% | Decreased by -373.87% Increased by +71.54% |